Everything asserted about the blend is inference from (a) the synergy principle demonstrated for GHRH + GHRP generally, [4] and (b) the individual-agent data above
Those are organism-level endpoints requiring controlled human trials, most of which have not been run for this compound, and none of them is established for research material or claimed here
Kessler says drugmakers should do more to inform patients about the risks of developing eating disorders, and gastroparesis a chronic condition where gastric emptying slows down significantly
Dose adjustments are managed through the portal between monthly cycles
Intake of sugars and refined carbs, alcohol, and foods high in saturated or trans fats should be limited, since they may worsen digestive discomfort
First, the drug slows how fast your stomach empties